Focal adhesion kinase-Reference-Cited by-同舟云学术

Focal adhesion kinase

Published:2014-04-23 Issue:7 Volume:15 Page:919-929
ISSN:1538-4047
Container-title:Cancer Biology & Therapy
language:en
Short-container-title:Cancer Biology & Therapy

Author:

Stone Rebecca L,Baggerly Keith A,Armaiz-Pena Guillermo N,Kang Yu,Sanguino Angela M,Thanapprapasr Duangmani,Dalton Heather J,Bottsford-Miller Justin,Zand Behrouz,Akbani Rehan,Diao Lixia,Nick Alpa M,DeGeest Koen,Lopez-Berestein Gabriel,Coleman Robert L,Lutgendorf Susan,Sood Anil K

Publisher

Informa UK Limited

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine

Link

http://www.tandfonline.com/doi/pdf/10.4161/cbt.28882

Reference52 articles.

1. Turning promise into progress for antiangiogenic agents in epithelial ovarian cancer

2. Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

3. Taking Cell-Matrix Adhesions to the Third Dimension

4. FAK Signaling in Neoplastic Disorders: A Linkage between Inflammation and Cancer

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel selective FAK inhibitor E2 inhibits ovarian cancer metastasis and growth by inducing cytotoxic autophagy;Biochemical Pharmacology;2024-11

2. Focal adhesion kinase signaling – tumor vulnerabilities and clinical opportunities;Journal of Cell Science;2024-07-15

3. Focal adhesion kinase: from biological functions to therapeutic strategies;Experimental Hematology & Oncology;2023-09-25

4. Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer;Frontiers in Molecular Neuroscience;2022-12-16

5. Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer models;BMC Cancer;2022-07-11